|
1
|
Adivitiya and Khasa YP: The evolution of recombinant thrombolytics: Current status and future directions. Bioengineered. 8:331–358. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Banerjee A, Chisti Y and Banerjee UC: Streptokinase-a clinically useful thrombolytic agent. Biotechnol Adv. 22:287–307. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Grierson DS: Clinical pharmacology of streptokinase. In: Acute Coronary Care. Springer, New York, NY, pp67-74, 1985.
|
|
4
|
Gemmill JD, Hogg KJ, Douglas JT, Dunn FG, Lowe GD, Rae AP and Hillis WS: The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents-lack of relationship to pretreatment streptokinase resistance. Eur Heart J. 14:819–825. 1993.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kunamneni A, Abdelghani TT and Ellaiah P: Streptokinase-The drug of choice for thrombolytic therapy. J Thromb Thrombolysis. 23:9–23. 2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Aslanabadi N, Safaie N, Talebi F, Dousti S and Entezari-Maleki T: The streptokinase therapy complications and its associated risk factors in patients with acute ST elevation myocardial infarction. Iran J Pharm Res. 17 (Suppl 1):S53–S63. 2018.PubMed/NCBI
|
|
7
|
Kumolosasi E, Wei WS and Wee CE: The use of thrombolytic agents in acute myocardial infarction (AMI) patients. Int J Pharm Pharm Sci. 5:63–67. 2013.
|
|
8
|
El-Menyar A, Zubaid M, Almahmeed W, Sulaiman K, Alnabti A, Singh R and Al Suwaidi J: Killip classification in patients with acute coronary syndrome: Insight from a multicenter registry. Am J Emerg Med. 30:97–103. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ranganathan P, Pramesh CS and Aggarwal R: Common pitfalls in statistical analysis: Logistic regression. Perspect Clin Res. 8:148–151. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nagelkerke NJD: A note on a general definition of the coefficient of determination. Biometrika. 78:691–692. 1991.
|
|
11
|
Nakamura M: Angiography is the gold standard and objective evidence of myocardial ischemia is mandatory if lesion severity is questionable. -Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Pro)-. Circ J. 75204–210. (217)2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lew AS, Laramee P, Cercek B, Shah PK and Ganz W: The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction. Circulation. 72:1321–1326. 1985.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Battershill PE, Benfield P and Goa KL: Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients. Drugs Aging. 4:63–86. 1994.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Carnemolla R and Muzykantov VR: Vascular targeting of antithrombotic agents. IUBMB Life. 63:632–639. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ghaffari S, Kazemi B and Golzari IG: Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: A double blind randomized clinical trial. Cardiovasc Ther. 31:53–59. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Srimahachota S, Sangwatanaroj S, Boonyaratavej S, Suitichaiyakul T and Ngarmukos P: Efficacy of rapid infusion of streptokinase in patients with acute myocardial infarction. J Med Assoc Thai. 83:8–12. 2000.PubMed/NCBI
|
|
17
|
Tatu-Chiţoiu G, Dorobanţu M, Teodorescu C, Craiu E, Vintilǎ M, Minescu B, Burghină D, Stamate S, Serban L, Protopopescu T, et al: Accelerated streptokinase in ST-elevation myocardial infarction-a romanian (ASK-ROMANIA) multicenter registry. Int J Cardiol. 122:216–223. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Herlitz J, Hartford M, Aune S and Karlsson T: Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy. Am J Cardiol. 71:1021–1024. 1993.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Koren G, Weiss AT, Ben-David Y, Hasin Y, Luria MH and Gotsman MS: Bradycardia and hypotension following reperfusion with streptokinase (Bezold-Jarisch reflex): A sign of coronary thrombolysis and myocardial salvage. Am Heart J. 112:468–471. 1986.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pachaï A, Erlendsson AK and Brandslund I: Streptokinase, complement activation and hypotension. APMIS. 105:650–654. 1997.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chau HW and Choi KK: Efficacy and safety of tenectaplase versus streptokinase in treating st-elevation myocardial infarction patients in Hong Kong: A four-year retrospective review in Queen Elizabeth Hospital. Hong Kong J Emerg Med. 20:359–363. 2013.
|
|
22
|
Killip T III and Kimball JT: Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 20:457–464. 1967.PubMed/NCBI View Article : Google Scholar
|
